G

Guangdong Marubi Biotechnology Co Ltd
SSE:603983

Watchlist Manager
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Watchlist
Price: 34.14 CNY -0.58%
Market Cap: 13.7B CNY
Have any thoughts about
Guangdong Marubi Biotechnology Co Ltd?
Write Note
Guangdong Marubi Biotechnology Co Ltd
/
Income Statement
/
Income from Continuing Operations

Guangdong Marubi Biotechnology Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangdong Marubi Biotechnology Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
G
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Income from Continuing Operations
¥342.9m
CAGR 3-Years
9%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Income from Continuing Operations
¥3B
CAGR 3-Years
-11%
CAGR 5-Years
-4%
CAGR 10-Years
0%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Income from Continuing Operations
¥657.2m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Income from Continuing Operations
¥1.5B
CAGR 3-Years
41%
CAGR 5-Years
34%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Income from Continuing Operations
¥1.8B
CAGR 3-Years
5%
CAGR 5-Years
14%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Income from Continuing Operations
¥1.4B
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Guangdong Marubi Biotechnology Co Ltd
Glance View

Market Cap
13.7B CNY
Industry
Consumer products

Guangdong Marubi Biotechnology Co Ltd stands as a compelling narrative of innovation and heritage in the realm of beauty and skincare. Established in 2002, the company has carved a niche in China’s competitive cosmetics industry by blending advanced biotechnology with traditional skincare practices. This fusion forms the backbone of Marubi’s product portfolio, which spans an array of skincare solutions including anti-aging serums, hydrating masks, and rejuvenating creams. The company’s strength lies in its robust research and development framework, where scientific rigor meets the potential of natural ingredients, leading to the formulation of effective skincare products. By fostering partnerships with renowned research institutions, Marubi ensures that its offerings are not only well-aligned with consumer expectations but also backed by solid scientific evidence. In the financial landscape, Marubi’s operational model is keenly focused on understanding consumer trends and leveraging digital marketing strategies to solidify its market position. A significant portion of the company’s revenues is generated through e-commerce platforms, which tap into China’s rapidly growing online retail market. Emphasizing brand loyalty and customer engagement, Marubi has utilized social media and collaborations with influencers to promote its products and extend its reach beyond traditional retail channels. Moreover, the company has established a keen presence in offline sales, ensuring its brand stands out in both bustling urban centers and emerging local markets. Through this strategic synergy between online and offline sales avenues, Guangdong Marubi Biotechnology Co Ltd thrives as a modern skincare powerhouse, creating value continuously in an ever-evolving market landscape.

Intrinsic Value
31.9 CNY
Overvaluation 7%
Intrinsic Value
Price
G
What is Intrinsic Value?

See Also

What is Guangdong Marubi Biotechnology Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
342.9m CNY

Based on the financial report for Sep 30, 2024, Guangdong Marubi Biotechnology Co Ltd's Income from Continuing Operations amounts to 342.9m CNY.

What is Guangdong Marubi Biotechnology Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-9%

Over the last year, the Income from Continuing Operations growth was 51%. The average annual Income from Continuing Operations growth rates for Guangdong Marubi Biotechnology Co Ltd have been 9% over the past three years , -9% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.